Application 219371
- Type
- ANDA
- Sponsor
- TEVA PHARMACEUTICALS DEVELOPMENT INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | NINTEDANIB | NINTEDANIB | CAPSULE | 100MG | No | No |
| 003 | NINTEDANIB | NINTEDANIB | CAPSULE | 25MG | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nintedanib | NINTEDANIB | Edenbridge Pharmaceuticals LLC. | 43dae004-eaf6-4411-8c3d-db7ab2c3b41e | 2026-07-29 | Warnings, Adverse reactions | Nintedanib NINTEDANIB |
| nintedanib | NINTEDANIB | AvKARE | 572722d7-338a-e4d2-e063-6394a90a257c | 2026-07-21 | Warnings, Adverse reactions | nintedanib NINTEDANIB |
| nintedanib | NINTEDANIB | Glenmark Pharmaceuticals Inc., USA | b14164fb-0276-4ad1-a5ff-400ab9e292da | 2026-07-10 | Warnings, Adverse reactions | nintedanib NINTEDANIB |
| nintedanib | NINTEDANIB | EPIC PHARMA LLC | 0e12f080-fcb4-465f-b988-4fa2c79f49aa | 2026-07-09 | Warnings, Adverse reactions | nintedanib NINTEDANIB |
| Nintedanib | NINTEDANIB | Golden State Medical Supply, Inc. | 4ecf7f05-4a95-b98c-e063-6394a90ab896 | 2026-06-16 | Warnings, Adverse reactions | Nintedanib NINTEDANIB |
| Nintedanib Capsules, 100 mg and 150 mg | NINTEDANIB | EXELAN PHARMACEUTICALS INC. | 60d8104e-cb6c-4f4f-8159-95ed57346ffa | 2026-04-21 | Warnings, Adverse reactions | NINTEDANIB |
| Nintedanib | NINTEDANIB | Cipla USA Inc. | 4d017c42-a823-452d-bc6f-0491dd9823e3 | 2026-04-02 | Warnings, Adverse reactions | Nintedanib NINTEDANIB |
| Nintedanib | NINTEDANIB | Apotex Corp. | b72b26c3-7731-80c0-734b-a5f53a1d89ae | 2026-03-20 | Warnings, Adverse reactions | Nintedanib NINTEDANIB |
| nintedanib | NINTEDANIB | Sandoz Inc | 751c3473-35d6-47d6-b405-af16a989716c | 2026-01-20 | Warnings, Adverse reactions | nintedanib NINTEDANIB |
| Nintedanib | NINTEDANIB | Dr. Reddy's Laboratories Inc. | 88f8600d-0974-51ca-6f8e-28c48a379e08 | 2025-11-20 | Warnings, Adverse reactions | Nintedanib NINTEDANIB |
| Ofev | NINTEDANIB | Boehringer Ingelheim Pharmaceuticals, Inc. | da1c9f37-779e-4682-816f-93d0faa4cfc9 | 2025-11-20 | Warnings, Adverse reactions | NINTEDANIB |